Robotic-Assisted vs Nonrobotic-Assisted Minimally Invasive Transforaminal Lumbar Interbody Fusion: A Cost-Utility Analysis.

Diogo GarciaOluwaseun O AkinduroGaetano De BiaseBernardo Sousa-PintoDaniel J JerreldRuchita DholakiaBijan BorahEric NottmeierH Gordon DeenW Christopher FoxMohamad BydonSelby ChenAlfredo Quinones-HinojosaKingsley Abode-Iyamah

Published in: Neurosurgery (2022)

Our results suggest that at a willingness to pay of $50 000/QALY, robotic-assisted MIS-TLIF was cost-effective in 63% of simulations. Cost-effectiveness depends on operating room and room (admission) costs, with potentially different results under distinct neurosurgical practices.

Keyphrases

minimally invasive
primary care
healthcare
emergency department
robot assisted
molecular dynamics
health insurance